125 related articles for article (PubMed ID: 37871911)
1. SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis.
Ferrena A; Wang J; Zhang R; Karadal-Ferrena B; Al-Hardan W; Singh S; Borjihan H; Schwartz EL; Zhao H; Oktay MH; Yang R; Geller DS; Hoang BH; Zheng D
Mol Cancer Ther; 2024 Feb; 23(2):223-234. PubMed ID: 37871911
[TBL] [Abstract][Full Text] [Related]
2. SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis.
Ferrena A; Wang J; Zhang R; Karadal-Ferrena B; Al-Hardan W; Singh S; Borjihan H; Schwartz E; Zhao H; Yang R; Geller D; Hoang B; Zheng D
bioRxiv; 2023 May; ():. PubMed ID: 37214958
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of SCF
Wang J; Ferrena A; Zhang R; Singh S; Viscarret V; Al-Harden W; Aldahamsheh O; Borjihan H; Singla A; Yaguare S; Tingling J; Zi X; Lo Y; Gorlick R; Schwartz EL; Zhao H; Yang R; Geller DS; Zheng D; Hoang BH
Oncogene; 2024 Mar; 43(13):962-975. PubMed ID: 38355807
[TBL] [Abstract][Full Text] [Related]
4. The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma.
Wang J; Aldahamsheh O; Ferrena A; Borjihan H; Singla A; Yaguare S; Singh S; Viscarret V; Tingling J; Zi X; Lo Y; Gorlick R; Zheng D; Schwartz EL; Zhao H; Yang R; Geller DS; Hoang BH
Ann N Y Acad Sci; 2021 Apr; 1490(1):90-104. PubMed ID: 33594717
[TBL] [Abstract][Full Text] [Related]
5. Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis.
Zhao H; Wang H; Bauzon F; Lu Z; Fu H; Cui J; Zhu L
J Biol Chem; 2016 May; 291(19):10201-9. PubMed ID: 26966181
[TBL] [Abstract][Full Text] [Related]
6. Targeted Inhibition of the E3 Ligase SCF
Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L
Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224
[TBL] [Abstract][Full Text] [Related]
7. p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.
Zhao H; Lu Z; Bauzon F; Fu H; Cui J; Locker J; Zhu L
Oncogene; 2017 Jan; 36(1):60-70. PubMed ID: 27181203
[TBL] [Abstract][Full Text] [Related]
8. Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice.
Wang H; Bauzon F; Ji P; Xu X; Sun D; Locker J; Sellers RS; Nakayama K; Nakayama KI; Cobrinik D; Zhu L
Nat Genet; 2010 Jan; 42(1):83-8. PubMed ID: 19966802
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma.
Zhang Y; Zvi YS; Batko B; Zaphiros N; O'Donnell EF; Wang J; Sato K; Yang R; Geller DS; Koirala P; Zhang W; Du X; Piperdi S; Liu Y; Zheng D; Roth M; Gill J; Zhang J; Ren T; Gorlick R; Zi X; Hoang BH
Sci Rep; 2018 Sep; 8(1):14294. PubMed ID: 30250282
[TBL] [Abstract][Full Text] [Related]
10. Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA.
Mutsaers AJ; Ng AJ; Baker EK; Russell MR; Chalk AM; Wall M; Liddicoat BJ; Ho PW; Slavin JL; Goradia A; Martin TJ; Purton LE; Dickins RA; Walkley CR
Bone; 2013 Jul; 55(1):166-78. PubMed ID: 23486187
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast-specific inactivation of p53 results in locally increased bone formation.
Liao N; Koehne T; Tuckermann J; Triviai I; Amling M; David JP; Schinke T; Luther J
PLoS One; 2021; 16(11):e0249894. PubMed ID: 34793446
[TBL] [Abstract][Full Text] [Related]
12. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
[TBL] [Abstract][Full Text] [Related]
13. MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein.
Ding L; Sun R; Yan Q; Wang C; Han X; Cui Y; Li R; Liu J
Aging (Albany NY); 2021 Feb; 13(5):6724-6739. PubMed ID: 33621206
[TBL] [Abstract][Full Text] [Related]
14. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
15. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
Gupta P; Zhao H; Hoang B; Schwartz EL
Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
[TBL] [Abstract][Full Text] [Related]
16. [Protein expression of Skp2 in osteosarcoma and its relation with prognosis].
Liao QD; Zhong D; Chen Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):606-11. PubMed ID: 18667774
[TBL] [Abstract][Full Text] [Related]
17. Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity.
Lu Z; Bauzon F; Fu H; Cui J; Zhao H; Nakayama K; Nakayama KI; Zhu L
Nat Commun; 2014 Mar; 5():3463. PubMed ID: 24632684
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting Skp2 E3 Ligase Suppresses Bleomycin-Induced Pulmonary Fibrosis.
Mikamo M; Kitagawa K; Sakai S; Uchida C; Ohhata T; Nishimoto K; Niida H; Suzuki S; Nakayama KI; Inui N; Suda T; Kitagawa M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415439
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Skp2 suppresses the proliferation and invasion of osteosarcoma cells.
Ding L; Li R; Han X; Zhou Y; Zhang H; Cui Y; Wang W; Bai J
Oncol Rep; 2017 Aug; 38(2):933-940. PubMed ID: 28627672
[TBL] [Abstract][Full Text] [Related]
20. S-phase kinase-associated protein 2 promotes cell growth and motility in osteosarcoma cells.
Ding L; Li R; Sun R; Zhou Y; Zhou Y; Han X; Cui Y; Wang W; Lv Q; Bai J
Cell Cycle; 2017 Aug; 16(16):1547-1555. PubMed ID: 28771075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
